Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04428619 · ClinicalTrials.gov registry record · NA
Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel Syndrome
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04428619 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 15 participants.
The verdict
NCT04428619, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a prospective, double-blind, randomized, sham-controlled pilot study evaluating the efficacy of percutaneous electrical nerve field stimulation for the treatment of adult patients with irritable bowel syndrome (IBS).
Interventions
- DEVICE Sham Device
- DEVICE Peripheral Electrical Nerve Field Stimulation (PENFS) Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2023-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04428619
The ClinicalTrials.gov registry entry for NCT04428619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Device is the first listed.
NCT04428619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04428619 about?
NCT04428619 is a clinical study titled "Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel Syndrome". This is a prospective, double-blind, randomized, sham-controlled pilot study evaluating the efficacy of percutaneous electrical nerve field stimulation for the treatment of adult patients with irritable bowel syndrome (IBS).
What is the current status of trial NCT04428619?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-08-01. Estimated completion is 2023-02-14.
What interventions are being tested in trial NCT04428619?
The interventions under investigation include: Sham Device (DEVICE), Peripheral Electrical Nerve Field Stimulation (PENFS) Device (DEVICE).
Who is sponsoring clinical trial NCT04428619?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.